Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Product Formulation on PK/PD of Cannabis Edibles
NCT05602649Phase 1Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Jul 2024
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol (9 arms), sponsored by Johns Hopkins University. Primary endpoints: Working memory performance as assessed by the Correct Trials on Paced Auditory Serial Addition Task at 8 hours, Psychomotor performance as assessed by the Correct Trials on the Digit Symbol Substitution Task at 8 hours and 7 more. Started Jul 2024; status: recruiting.
02
Drugs
dronabinol
Beyond the preview
Go deeper on NCT05602649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05602649.